29.08.2017 20:49:00
|
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
NEW YORK, Aug. 29, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS) and certain of its officers on behalf of a class consisting of investors who purchased PetMed securities between May 8, 2017 through August 23, 2017, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/pets.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) PetMed was marketing dangerous and addictive animal drugs to humans; (2) as such, PetMed is vulnerable to potential civil or criminal liability, as well as other regulatory action; (3) in turn, Google may halt PetMed's advertising activities; and (4) consequently, defendants' statements about PetMed's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On August 23, 2017, Aurelius Value published an article alleging that PetMed targets opioid users with Google ads and other marketing techniques aimed at facilitating the abuse of opioids. Following this news, PetMed stock dropped.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/pets or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in PetMed you have until October 24, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-petmed-express-inc-pets--lead-plaintiff-deadline-october-24-2017-300511014.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PetMed Express Inc.mehr Nachrichten
16.12.24 |
NASDAQ Composite Index-Papier PetMed Express-Aktie: So viel Verlust hätte ein Investment in PetMed Express von vor 5 Jahren bedeutet (finanzen.at) | |
11.12.24 |
Börse New York in Grün: NASDAQ Composite liegt zum Ende des Mittwochshandels im Plus (finanzen.at) | |
11.12.24 |
Börse New York in Grün: NASDAQ Composite klettert am Nachmittag (finanzen.at) | |
11.12.24 |
Freundlicher Handel: NASDAQ Composite legt am Mittag zu (finanzen.at) | |
10.12.24 |
Starker Wochentag in New York: Anleger lassen NASDAQ Composite zum Start steigen (finanzen.at) | |
09.12.24 |
Börse New York in Rot: NASDAQ Composite liegt zum Handelsende im Minus (finanzen.at) | |
09.12.24 |
Handel in New York: So entwickelt sich der NASDAQ Composite am Montagnachmittag (finanzen.at) | |
09.12.24 |
Anleger in New York halten sich zurück: NASDAQ Composite schwächelt (finanzen.at) |